☆ 4.7 Article

Health Technology Assessment of Advanced Therapy Medicinal Products: Comparison Among 3 European Countries

FRONTIERS IN PHARMACOLOGY (2021)

Related references

Note: Only part of the references are listed.

Review Oncology

Fertility Preservation in Female Pediatric Patients With Cancer: A Clinical and Regulatory Issue

Serena Brancati et al.

Summary: Fertility preservation is crucial for cancer patients, with GnRHa treatment serving as a valuable alternative, but there is still a lack of medical options for adolescents.

FRONTIERS IN ONCOLOGY (2021)

Add to Collection

Review Immunology

Rituximab in Multiple Sclerosis: Are We Ready for Regulatory Approval?

Serena Brancati et al.

Summary: Rituximab has been shown to be a highly effective alternative in treating multiple sclerosis, with good effectiveness, safety, and patient compliance. Despite its off-label use in some countries, national regulatory authorities could officially recognize its usage through specific procedures to ensure equal access for patients to a safe and effective option.

FRONTIERS IN IMMUNOLOGY (2021)

Add to Collection

Article Health Policy & Services

Price and reimbursement of advanced therapeutic medicinal products in Europe: are assessment and appraisal diverging from expert recommendations?

Virginia Ronco et al.

Summary: The reimbursement status of ATMPs varies across the European Major five (EU5) countries, with CAR-T being reimbursed in all countries. Outcome-based Managed Entry Agreements (MEAs) are extensively used for ATMPs. Extra funds for hospitals managing ATMPs are only provided in Germany, with additional funding in France.

JOURNAL OF PHARMACEUTICAL POLICY AND PRACTICE (2021)

Add to Collection

Article Pharmacology & Pharmacy

Implementation of Value-based Pricing for Medicines

Claudio Jommi et al.

CLINICAL THERAPEUTICS (2020)

Add to Collection

Editorial Material Pharmacology & Pharmacy

The Regulatory Challenges for Drug Repurposing During the Covid-19 Pandemic: The Italian Experience

Lucia Gozzo et al.

FRONTIERS IN PHARMACOLOGY (2020)

Add to Collection

Editorial Material Pharmacology & Pharmacy

Dexamethasone Treatment for Covid-19, a Curious Precedent Highlighting a Regulatory Gap

Lucia Gozzo et al.

FRONTIERS IN PHARMACOLOGY (2020)

Add to Collection

Editorial Material Medicine, Research & Experimental

Innovation and competition in advanced therapy medicinal products

Enrique Seoane-Vazquez et al.

EMBO MOLECULAR MEDICINE (2019)

Add to Collection

Article Health Care Sciences & Services

Value-Based Pricing for Emerging Gene Therapies: The Economic Case for a Higher Cost-Effectiveness Threshold

Louis P. Garrison et al.

JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY (2019)

Add to Collection

Article Economics

Analytic Considerations in Applying a General Economic Evaluation Reference Case to Gene Therapy

Michael F. Drummond et al.

VALUE IN HEALTH (2019)

Add to Collection

Article Economics

Estimating the Clinical Pipeline of Cell and Gene Therapies and Their Potential Economic Impact on the US Healthcare System

Casey Quinn et al.

VALUE IN HEALTH (2019)

Add to Collection

Article Economics

Advanced therapy medicinal products and health technology assessment principles and practices for value-based and sustainable healthcare

Bengt Jonsson et al.

EUROPEAN JOURNAL OF HEALTH ECONOMICS (2019)

Add to Collection

Article Economics

Using health technology assessment to assess the value of new medicines: results of a systematic review and expert consultation across eight European countries

Aris Angelis et al.

EUROPEAN JOURNAL OF HEALTH ECONOMICS (2018)

Add to Collection

Article Health Care Sciences & Services

The assessment and appraisal of regenerative medicines and cell therapy products: an exploration of methods for review, economic evaluation and appraisal

Robert Hettle et al.

HEALTH TECHNOLOGY ASSESSMENT (2017)

Add to Collection

Article Economics

Variation in Health Technology Assessment and Reimbursement Processes in Europe

Ronald L. Akehurst et al.

VALUE IN HEALTH (2017)

Add to Collection

Article Pharmacology & Pharmacy

A Comparison of Reimbursement Recommendations by European HTA Agencies: Is There Opportunity for Further Alignment?

Nicola Allen et al.

FRONTIERS IN PHARMACOLOGY (2017)

Add to Collection

Article Economics

Benefit assessment in Germany: implications for price discounts

Ulrike Theidel et al.

HEALTH ECONOMICS REVIEW (2016)

Add to Collection

Review Chemistry, Medicinal

The role of health technology assessment bodies in shaping drug development

Oriana Ciani et al.

DRUG DESIGN DEVELOPMENT AND THERAPY (2014)

Add to Collection

Article Pharmacology & Pharmacy

Health economics and outcomes research within drug development

Floortje van Nooten et al.

DRUG DISCOVERY TODAY (2012)

Add to Collection

© Peeref 2019-2024. All rights reserved.